003520 — Yungjin Pharm Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapSucker Stock

Annual cashflow statement for Yungjin Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-11,582	-21,961	-3,876	1,233	-228
Depreciation
Amortisation
Non-Cash Items	12,867	24,107	12,102	14,481	11,113
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-276	-21,517	-27,125	-2,669	-7,921
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	8,368	-11,610	-10,224	21,741	11,730
Capital Expenditures	-11,320	-13,200	-10,238	-21,607	-11,964
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-318	-152	-2,780	3,306	102
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-11,638	-13,352	-13,017	-18,302	-11,861
Financing Cash Flow Items	-250	-870	-2,278	-1,086	-1,530
Other Financing Cash Flow
Net Issuance / Retirement of Debt
Cash from Financing Activities	3,307	25,180	29,766	-7,212	25,122
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	36.9	218	6,525	-3,772	24,991